Amir Reichman
CIK: 0001960199
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SCNI
Scinai Immunotherapeutics Ltd.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Reichman Amir
Reichman Amir (SEC CIK 0001960199) files insider reports with the SEC as Chief Executive Officer of Scinai Immunotherapeutics Ltd. (SCNI).
Signal8 holds 2 ownership filings by Reichman Amir (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Jun 18, 2026. Those filings report 1 transaction, the latest on Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Reichman Amir's filings is in JERUSALEM.
Recent filings by Reichman Amir
- Jun 16, 2026: Grant or award of SCNI shares (Form 4, code A).
Other insiders filing for Scinai Immunotherapeutics Ltd. (SCNI)
- GERMAIN MARK, Director
- Mark Elad, Chief Operating Officer
- MARGOLIN YAEL, Director
- Ben-Or Uri, Director
- Moed Samuel J, Director
- Green Jay, Director